 | • レポートコード：MRC2012A6646 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、オレンシア（アバタセプト）医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。オレンシア（アバタセプト）医薬品の種類別市場規模（プレフィルドシリンジ、バイアル）、用途別市場規模（関節リウマチ、乾癬性関節炎、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bristol-Myers Squibb、 ・地域別グローバル市場分析 2015年-2020年 ・オレンシア（アバタセプト）医薬品の北米市場（アメリカ、カナダ、メキシコ） ・オレンシア（アバタセプト）医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・オレンシア（アバタセプト）医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・オレンシア（アバタセプト）医薬品の南米市場（ブラジル、アルゼンチン） ・オレンシア（アバタセプト）医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プレフィルドシリンジ、バイアル ・用途別分析：関節リウマチ、乾癬性関節炎、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Orencia (abatacept) Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Orencia (abatacept) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Orencia (abatacept) Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Orencia (abatacept) Drug market has been segmented into
Prefilled Syringe
Vial
By Application, Orencia (abatacept) Drug has been segmented into:
Rheumatoid Arthritis
Psoriatic Arthritis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Orencia (abatacept) Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Orencia (abatacept) Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Orencia (abatacept) Drug market.
The report offers in-depth assessment of the growth and other aspects of the Orencia (abatacept) Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Orencia (abatacept) Drug Market Share Analysis
Orencia (abatacept) Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Orencia (abatacept) Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Orencia (abatacept) Drug sales, revenue and market share for each player covered in this report.
The major players covered in Orencia (abatacept) Drug are:
Bristol-Myers Squibb
Among other players domestic and global, Orencia (abatacept) Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Orencia (abatacept) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Orencia (abatacept) Drug, with price, sales, revenue and global market share of Orencia (abatacept) Drug in 2018 and 2019.
Chapter 3, the Orencia (abatacept) Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Orencia (abatacept) Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Orencia (abatacept) Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Orencia (abatacept) Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Orencia (abatacept) Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Orencia (abatacept) Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Prefilled Syringe
1.2.3 Vial
1.3 Market Analysis by Application
1.3.1 Overview: Global Orencia (abatacept) Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Rheumatoid Arthritis
1.3.3 Psoriatic Arthritis
1.3.4 Other
1.4 Overview of Global Orencia (abatacept) Drug Market
1.4.1 Global Orencia (abatacept) Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bristol-Myers Squibb SWOT Analysis
2.1.4 Bristol-Myers Squibb Product and Services
2.1.5 Bristol-Myers Squibb Orencia (abatacept) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Orencia (abatacept) Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Orencia (abatacept) Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Orencia (abatacept) Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Orencia (abatacept) Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Orencia (abatacept) Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Orencia (abatacept) Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Orencia (abatacept) Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
4.3 Europe Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
4.5 South America Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Orencia (abatacept) Drug Sales, Revenue and Market Share by Country
5.1.1 North America Orencia (abatacept) Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Orencia (abatacept) Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
5.3 Canada Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Orencia (abatacept) Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Orencia (abatacept) Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Orencia (abatacept) Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
6.3 UK Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
6.4 France Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
6.5 Russia Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
6.6 Italy Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Orencia (abatacept) Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Orencia (abatacept) Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Orencia (abatacept) Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
7.3 Japan Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
7.4 Korea Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
7.5 India Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
7.7 Australia Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Orencia (abatacept) Drug Sales, Revenue and Market Share by Country
8.1.1 South America Orencia (abatacept) Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Orencia (abatacept) Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Orencia (abatacept) Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Orencia (abatacept) Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Orencia (abatacept) Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Orencia (abatacept) Drug Sales and Market Share by Type (2015-2020)
10.2 Global Orencia (abatacept) Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Orencia (abatacept) Drug Price by Type (2015-2020)
11 Global Orencia (abatacept) Drug Market Segment by Application
11.1 Global Orencia (abatacept) Drug Sales Market Share by Application (2015-2020)
11.2 Global Orencia (abatacept) Drug Revenue Market Share by Application (2015-2020)
11.3 Global Orencia (abatacept) Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Orencia (abatacept) Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Orencia (abatacept) Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Orencia (abatacept) Drug Market Forecast (2021-2025)
12.2.2 Europe Orencia (abatacept) Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Orencia (abatacept) Drug Market Forecast (2021-2025)
12.2.4 South America Orencia (abatacept) Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Orencia (abatacept) Drug Market Forecast (2021-2025)
12.3 Orencia (abatacept) Drug Market Forecast by Type (2021-2025)
12.3.1 Global Orencia (abatacept) Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Orencia (abatacept) Drug Market Share Forecast by Type (2021-2025)
12.4 Orencia (abatacept) Drug Market Forecast by Application (2021-2025)
12.4.1 Global Orencia (abatacept) Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Orencia (abatacept) Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Orencia (abatacept) Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Orencia (abatacept) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Orencia (abatacept) Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 8. Bristol-Myers Squibb Orencia (abatacept) Drug Major Business
Table 9. Bristol-Myers Squibb Orencia (abatacept) Drug Total Revenue (USD Million) (2017-2018)
Table 10. Bristol-Myers Squibb SWOT Analysis
Table 11. Bristol-Myers Squibb Orencia (abatacept) Drug Product and Services
Table 12. Bristol-Myers Squibb Orencia (abatacept) Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Global Orencia (abatacept) Drug Sales by Manufacturer (2018-2019) (K Units)
Table 14. Global Orencia (abatacept) Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 15. Global Orencia (abatacept) Drug Sales by Regions (2015-2020) (K Units)
Table 16. Global Orencia (abatacept) Drug Sales Market Share by Regions (2015-2020)
Table 17. Global Orencia (abatacept) Drug Revenue by Regions (2015-2020) (USD Million)
Table 18. North America Orencia (abatacept) Drug Sales by Countries (2015-2020) (K Units)
Table 19. North America Orencia (abatacept) Drug Sales Market Share by Countries (2015-2020)
Table 20. North America Orencia (abatacept) Drug Revenue by Countries (2015-2020) (USD Million)
Table 21. North America Orencia (abatacept) Drug Revenue Market Share by Countries (2015-2020)
Table 22. Europe Orencia (abatacept) Drug Sales by Countries (2015-2020) (K Units)
Table 23. Europe Orencia (abatacept) Drug Sales Market Share by Countries (2015-2020)
Table 24. Europe Orencia (abatacept) Drug Revenue by Countries (2015-2020) (USD Million)
Table 25. Asia-Pacific Orencia (abatacept) Drug Sales by Regions (2015-2020) (K Units)
Table 26. Asia-Pacific Orencia (abatacept) Drug Sales Market Share by Regions (2015-2020)
Table 27. Asia-Pacific Orencia (abatacept) Drug Revenue by Regions (2015-2020) (USD Million)
Table 28. South America Orencia (abatacept) Drug Sales by Countries (2015-2020) (K Units)
Table 29. South America Orencia (abatacept) Drug Sales Market Share by Countries (2015-2020)
Table 30. South America Orencia (abatacept) Drug Revenue by Countries (2015-2020) (USD Million)
Table 31. South America Orencia (abatacept) Drug Revenue Market Share by Countries (2015-2020)
Table 32. Middle East & Africa Orencia (abatacept) Drug Sales by Countries (2015-2020) (K Units)
Table 33. Middle East & Africa Orencia (abatacept) Drug Sales Market Share by Countries (2015-2020)
Table 34. Middle East & Africa Orencia (abatacept) Drug Revenue by Countries (2015-2020) (USD Million)
Table 35. Middle East & Africa Orencia (abatacept) Drug Revenue Market Share by Countries (2015-2020)
Table 36. Global Orencia (abatacept) Drug Sales by Type (2015-2020) (K Units)
Table 37. Global Orencia (abatacept) Drug Sales Share by Type (2015-2020)
Table 38. Global Orencia (abatacept) Drug Revenue by Type (2015-2020) (USD Million)
Table 39. Global Orencia (abatacept) Drug Revenue Share by Type (2015-2020)
Table 40. Global Orencia (abatacept) Drug Sales by Application (2015-2020) (K Units)
Table 41. Global Orencia (abatacept) Drug Sales Share by Application (2015-2020)
Table 42. Global Orencia (abatacept) Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 43. Global Orencia (abatacept) Drug Market Share Forecast by Regions (2021-2025)
Table 44. Global Orencia (abatacept) Drug Sales Forecast by Type (2021-2025) (K Units)
Table 45. Global Orencia (abatacept) Drug Market Share Forecast by Type (2021-2025)
Table 46. Global Orencia (abatacept) Drug Sales Forecast by Application (2021-2025)
Table 47. Global Orencia (abatacept) Drug Market Share Forecast by Application (2021-2025)
Table 48. Direct Channel Pros & Cons
Table 49. Indirect Channel Pros & Cons
Table 50. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Orencia (abatacept) Drug Picture
Figure 2. Global Sales Market Share of Orencia (abatacept) Drug by Type in 2019
Figure 3. Prefilled Syringe Picture
Figure 4. Vial Picture
Figure 5. Orencia (abatacept) Drug Sales Market Share by Application in 2018
Figure 6. Rheumatoid Arthritis Picture
Figure 7. Psoriatic Arthritis Picture
Figure 8. Other Picture
Figure 9. Global Orencia (abatacept) Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Orencia (abatacept) Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Orencia (abatacept) Drug Sales Market Share by Manufacturer in 2019
Figure 30. Global Orencia (abatacept) Drug Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Orencia (abatacept) Drug Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Orencia (abatacept) Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Orencia (abatacept) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Orencia (abatacept) Drug Revenue Market Share by Regions (2015-2020)
Figure 37. Global Orencia (abatacept) Drug Revenue Market Share by Regions in 2018
Figure 38. North America Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
Figure 39. Europe Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
Figure 41. South America Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Orencia (abatacept) Drug Sales and Growth Rate (2015-2020)
Figure 43. North America Orencia (abatacept) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Orencia (abatacept) Drug Sales Market Share by Countries (2015-2020)
Figure 45. North America Orencia (abatacept) Drug Sales Market Share by Countries in 2018
Figure 46. North America Orencia (abatacept) Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Orencia (abatacept) Drug Revenue Market Share by Countries in 2018
Figure 48. United States Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Orencia (abatacept) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Orencia (abatacept) Drug Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Orencia (abatacept) Drug Revenue Market Share by Countries in 2019
Figure 54. Germany Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Orencia (abatacept) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Orencia (abatacept) Drug Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Orencia (abatacept) Drug Revenue Market Share by Regions 2019
Figure 62. China Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Orencia (abatacept) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Orencia (abatacept) Drug Sales Market Share by Countries in 2019
Figure 69. South America Orencia (abatacept) Drug Revenue Market Share by Countries in 2019
Figure 70. Brazil Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Orencia (abatacept) Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Orencia (abatacept) Drug Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Orencia (abatacept) Drug Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Orencia (abatacept) Drug Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Orencia (abatacept) Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Orencia (abatacept) Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Orencia (abatacept) Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Orencia (abatacept) Drug Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Orencia (abatacept) Drug Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Orencia (abatacept) Drug Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Orencia (abatacept) Drug Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Orencia (abatacept) Drug Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
関節リウマチ治療薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Rheumatoid Arthritis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Rheumatoid Arthriti…- 乾癬性関節炎治療薬の世界市場（～2026年） Psoriatic arthritis is a long-term inflammatory arthritis that occurs in people affected by the autoimmune disease psoriasis. The global psoriatic arthritis therapeutics market is expected to grow rapidly over the forecast period owing to the increasing prevalence rate of psoriatic arthritis. Market…
- 血清反応陽性用関節リウマチ治療薬の世界市場（～2026年） Arthritis means inflammation in a joint. The inflammation is characterized by swelling, pain, and redness within the joint. This type of arthritis is known to cause chronic inflammatory disorder in the hands and feet. The Americas dominated the overall market in terms of revenue in 2016 owing to the…
- 関節炎薬の世界市場（～2026年） Arthritis is condition that causes pain and inflammation in joints. Around 100 different types of arthritis related conditions present globally and it is one of the leading cause of disability worldwide. The most common types of arthritis includes: Psoriatic Arthritis, Rheumatoid Arthritis, Osteoart…
- 関節リウマチ治療の世界市場（～2026年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…